Details for New Drug Application (NDA): 020105
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
NDA 020105 describes TRIOSTAT, which is a drug marketed by Par Sterile Products and is included in one NDA. Additional details are available on the TRIOSTAT profile page.
The generic ingredient in TRIOSTAT is liothyronine sodium. There are four drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the liothyronine sodium profile page.
The generic ingredient in TRIOSTAT is liothyronine sodium. There are four drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the liothyronine sodium profile page.
Summary for 020105
| Tradename: | TRIOSTAT |
| Applicant: | Par Sterile Products |
| Ingredient: | liothyronine sodium |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 0.01MG BASE/ML | ||||
| Approval Date: | Dec 31, 1991 | TE: | AP | RLD: | Yes | ||||
Complete Access Available with Subscription
